Time

Topic

0:10

Please provide a brief overview of your career and current position

--

Harvard University/Brigham and Women’s Hospital

0:56

When did you start getting involved with ISPE?

--

Pre-ISPE- Minneapolis

2:03

Why was the time right to start a pharmacoepi organization?

--

Did not fit in clinical pharmacology or epidemiology

2:53

Enormous potential of data

4:52

Was there always an international presence at ICPE?

--

American and European in early days

5:49

Opportunity to expand globally

6:19

How did ISPE as an organization come about?

--

Hugh Tilson encouraged formalization

7:34

What were the biggest challenges for ISPE to get off the ground?

--

Defining a research program

8:40

Who comprises ISPE?

--

All disciplines- physicians, pharmacists, epidemiologists, nurses, industry, etc.

9:54

What do you feel is ISPE’s greatest impact on the field?

--

Community as a resource

10:47

What are your fondest memories of the ICPE meetings?

--

Finding a kindred group of researchers

11:47

What do you see as the future of ISPE?

--

Continued tremendous growth

13:23

How has ISPE evolved over the years?

--

Setting tone for best science in methodology

13:40

Growing into regulatory policy and cost-effectiveness

15:08

What wisdom would you like to pass to future leaders and members of ISPE?

--

Hard work pays off

16:20

Bring together disparate disciplines and constituencies